Oral LT3 therapy

triiodothyronine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral LT3 therapy, covering 2024-12-24 to 2024-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Developing Oral LT3 Therapy for Heart Failure - HFrEF [Phase 1, Phase 2]